DMAC logo

DiaMedica Therapeutics (DMAC) Company Overview

Profile

Full Name:

DiaMedica Therapeutics Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

August 3, 2012

Indexes:

Not included

Description:

DiaMedica Therapeutics (DMAC) is a biopharmaceutical company focused on developing innovative treatments for kidney and neurological diseases. They aim to improve patient outcomes through advanced therapies, particularly using their proprietary technology to enhance drug delivery and effectiveness.

Events Calendar

Earnings

Next earnings date:

Mar 20, 2025

Recent quarterly earnings:

Nov 13, 2024

Recent annual earnings:

Mar 20, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Nov 15, 2018

Analyst ratings

Recent major analysts updates

Nov 15, 24 HC Wainwright & Co.
Buy
Oct 10, 24 HC Wainwright & Co.
Buy
Oct 7, 24 HC Wainwright & Co.
Buy
Aug 16, 24 Oppenheimer
Outperform
Mar 21, 24 Oppenheimer
Outperform
Mar 21, 24 Craig-Hallum
Buy
Jun 22, 23 Oppenheimer
Outperform
Jul 7, 22 Oppenheimer
Perform
Jul 7, 22 Lake Street
Buy
Jul 7, 22 Craig-Hallum
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for DiaMedica Therapeutics?
  • Does DiaMedica Therapeutics pay dividends?
  • What sector is DiaMedica Therapeutics in?
  • What industry is DiaMedica Therapeutics in?
  • What country is DiaMedica Therapeutics based in?
  • When did DiaMedica Therapeutics go public?
  • Is DiaMedica Therapeutics in the S&P 500?
  • Is DiaMedica Therapeutics in the NASDAQ 100?
  • Is DiaMedica Therapeutics in the Dow Jones?
  • When was DiaMedica Therapeutics's last earnings report?
  • When does DiaMedica Therapeutics report earnings?
  • Should I buy DiaMedica Therapeutics stock now?

What is the ticker symbol for DiaMedica Therapeutics?

The ticker symbol for DiaMedica Therapeutics is NASDAQ:DMAC

Does DiaMedica Therapeutics pay dividends?

No, DiaMedica Therapeutics does not pay dividends

What sector is DiaMedica Therapeutics in?

DiaMedica Therapeutics is in the Healthcare sector

What industry is DiaMedica Therapeutics in?

DiaMedica Therapeutics is in the Biotechnology industry

What country is DiaMedica Therapeutics based in?

DiaMedica Therapeutics is headquartered in United States

When did DiaMedica Therapeutics go public?

DiaMedica Therapeutics's initial public offering (IPO) was on August 3, 2012

Is DiaMedica Therapeutics in the S&P 500?

No, DiaMedica Therapeutics is not included in the S&P 500 index

Is DiaMedica Therapeutics in the NASDAQ 100?

No, DiaMedica Therapeutics is not included in the NASDAQ 100 index

Is DiaMedica Therapeutics in the Dow Jones?

No, DiaMedica Therapeutics is not included in the Dow Jones index

When was DiaMedica Therapeutics's last earnings report?

DiaMedica Therapeutics's most recent earnings report was on Nov 13, 2024

When does DiaMedica Therapeutics report earnings?

The next expected earnings date for DiaMedica Therapeutics is Mar 20, 2025

Should I buy DiaMedica Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions